REBECCA MAHNE: Open Payments
NPI 1780152645 · LAKEWOOD RANCH, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$655 in 20 payments from 8 companies in 2025. Trend: 2023 $304 · 2024 $788 · 2025 $655
Food & beverage: $655
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 3 | $183 |
| UCB, Inc. | 4 | $138 |
| E.R. Squibb & Sons, L.L.C. | 1 | $87 |
| ABBVIE INC. | 3 | $73 |
| Galderma Laboratories, L.P. | 3 | $59 |
| Janssen Biotech, Inc. | 3 | $59 |
| Amgen Inc. | 2 | $40 |
| Helsinn Therapeutics (U.S.), Inc. | 1 | $17 |
Products named: Bimzelx, EBGLYSS, Sotyktu, TALTZ, TREMFYA, NEMLUVIO, SKYRIZI, OTEZLA.
Industry payments across FL — which companies pay providers there.
